A recent study indicates that patients who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who end conventional lifestyle regimens.
Research printed in a major health publication demonstrates that while overweight individuals often shed about a fifth of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such drugs must be aware of the potential of rapid weight regain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a return to original mass within about 18 months.
Comparing Approaches
The analysis, which reviewed dozens of studies involving thousands of participants, compared the effects of these new drugs with other pills.
Scientists emphasize that people who shed pounds through diet and exercise usually have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Nutrition scientists propose the mechanism of the jabs explains the heightened weight return.
The injections copy a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 levels far above than normal might result in the body to produce less of its own natural hormone, and may also reduce sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement means hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines advise the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals contend that, given the significant potential of relapse, the treatment might need to be ongoing.
This perspective is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of excess weight," akin to managing diseases like high blood pressure.
Patient Experiences
Users who have stopped the medication describe a sudden return of appetite.
"I experienced a switch that goes on and you become ravenous," recalled one woman.
This difficulty is exacerbated if patients have not adopted lasting lifestyle or habit modifications during therapy.
Growing Interest
Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is greater among women than men.
- The middle-aged demographic shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, researchers caution that while these medications are powerful tools for shedding pounds, they are not a magic cure and lasting health benefits likely depends on ongoing lifestyle support.
